Jacob van Naarden

Jacob van Naarden

Chief Executive Officer en LOXO ONCOLOGY INC .

Fortuna: 16 M $ al 31/03/2024

39 años
Finance
Health Technology
Consumer Services

Perfil

Jacob S.
van Naarden
is currently the Chief Executive Officer at Loxo Oncology, Inc. He is also the Director at Delfi Diagnostics, Inc. and the Executive Vice President at Eli Lilly & Co. Previously, he worked as an Analyst at HealthCor Management LP from 2013 to 2014.
Before that, he was an Associate at Aisling Capital LLC from 2008 to 2013.
He started his career as an Analyst at Goldman Sachs & Co. LLC from 2006 to 2008.
Mr. van Naarden completed his undergraduate degree at Princeton University in 2006.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
28/02/2024 20 489 ( 0.00% ) 16 M $ 31/03/2024

Cargos activos de Jacob van Naarden

EmpresasCargoInicio
LOXO ONCOLOGY INC Chief Executive Officer -
ELI LILLY AND COMPANY Corporate Officer/Principal -
Director/Board Member 22/06/2022
Todos los cargos activos de Jacob van Naarden

Antiguos cargos conocidos de Jacob van Naarden.

EmpresasCargoFin
Analyst-Equity 01/05/2014
Private Equity Analyst 01/01/2013
Analyst-Equity -
Ver el detalle de la experiencia de Jacob van Naarden.

Formación de Jacob van Naarden.

Princeton University Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Jacob van Naarden.

Relaciones

99

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas1
ELI LILLY AND COMPANY

Health Technology

Empresas privadas5

Finance

Finance

Finance

Health Technology

Health Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Jacob van Naarden